Magnus Grönberg, Author at Inify Laboratories

Inify Laboratories receives accreditation as a medical laboratory

Investor News 2023-11-06

STOCKHOLM – November 6, 2023 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics in pathology, has received accreditation as a medical laboratory according to the ISO 15189 […]

Inify Laboratories erhåller ackreditering som medicinskt laboratorium

Swedish news 2023-11-06

STOCKHOLM – 6 november 2023 – Inify Laboratories, en unik laboratorieverksamhet som tillhandahåller cancerdiagnostik inom patologi, har erhållit ackreditering som medicinskt laboratorium enligt standarden ISO 15189. ”Att bli ackrediterade […]

Kontinuerlig diagnostikverksamhet och mycket positiv kundrespons

Finansiella rapporter, Swedish news 2023-10-24

STOCKHOLM – 24 oktober 2023 – Inify Laboratories, en unik laboratorieverksamhet som tillhandahåller cancerdiagnostik inom patologi, har haft ett kontinuerligt inflöde av patientprover för diagnos, vilket är av största vikt […]

Continuous diagnostic operation and very positive feedback from customers

Financial reports, Investor News 2023-10-24

STOCKHOLM – October 24, 2023 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, has had a continuous inflow of patient samples for diagnosis, which is […]

Panel talk about Inify’s second quarter 2023

Investor News 2023-08-28

Listen to CEO Fredrik Palm and Laboratory Manager Emelie Edvigsson in this panel talk, led by Ole Eikeland, where they explain some of the success factors for Inify’s first laboratory. […]

Inify Laboratories – Lyckad laboratorielansering under Q2 med leverans av första prostatacancerdiagnoserna

Finansiella rapporter, Swedish news 2023-08-23

STOCKHOLM – 23 augusti 2023 – Inify Laboratories, en unik laboratorietjänst som tillhandahåller cancerdiagnostik inom patologi, lanserades framgångsrikt under andra kvartalet 2023. ”Vi lanserade vår laboratorietjänst i mitten av […]

Inify Laboratories – Successful laboratory launch in Q2 with delivery of first prostate cancer diagnosis

Financial reports, Investor News 2023-08-23

STOCKHOLM – August 23, 2023 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, successfully launched in the second quarter 2023. “We launched our laboratory service […]

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2023-07-05

Stockholm, Sweden, July 5, 2023; Inify Laboratories AB (publ.) has been notified that the following transaction has been completed by a close associate to a primary insider in Inify: Monsun […]

Finansavisen uppmärksammar Inify Laboratories

Swedish news 2023-07-03

Den norska tidningen Finansavisen uppmärksammar Inify Laboratories i ett reportage från laboratoriet i Solna. Här intervjuas VD Fredrik Palm och medicinske chefen Claes Lindh bland annat om vårdens utmaningar, marknadspotential och vad som gör Inify så unikt.

Finansavisen highlights Inify Laboratories

News 2023-07-03

Norwegian financial newspaper Finansavisen highlights Inify Laboratories in a report from the laboratory in Solna. CEO Fredrik Palm and Chief Medical Officer Claes Lindh discuss challenges in healthcare, market potential and what makes Inify so unique.

Inify Laboratories receives accreditation as a medical laboratory

Inify Laboratories erhåller ackreditering som medicinskt laboratorium

Kontinuerlig diagnostikverksamhet och mycket positiv kundrespons

Continuous diagnostic operation and very positive feedback from customers

Panel talk about Inify’s second quarter 2023

Inify Laboratories – Lyckad laboratorielansering under Q2 med leverans av första prostatacancerdiagnoserna

Inify Laboratories – Successful laboratory launch in Q2 with delivery of first prostate cancer diagnosis

Inify Laboratories – mandatory notification of trade

Finansavisen uppmärksammar Inify Laboratories

Finansavisen highlights Inify Laboratories

Our services

Inify Laboratories

For Investors

Contact us

Social media